- Home
- ZIMV vs AMRN Comparison
ZIMV vs AMRN Comparison
Compare ZIMV & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- AMRN
- Stock Information
- Founded
- ZIMV 2021
- AMRN 1989
- Country
- ZIMV United States
- AMRN Ireland
- Employees
- ZIMV N/A
- AMRN N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ZIMV Health Care
- AMRN Health Care
- Exchange
- ZIMV Nasdaq
- AMRN Nasdaq
- Market Cap
- ZIMV 262.9M
- AMRN 216.0M
- IPO Year
- ZIMV N/A
- AMRN 1993
- Fundamental
- Price
- ZIMV $18.78
- AMRN $15.59
- Analyst Decision
- ZIMV Hold
- AMRN Strong Sell
- Analyst Count
- ZIMV 3
- AMRN 1
- Target Price
- ZIMV $14.50
- AMRN $12.00
- AVG Volume (30 Days)
- ZIMV 779.6K
- AMRN 169.7K
- Earning Date
- ZIMV 08-04-2025
- AMRN 07-30-2025
- Dividend Yield
- ZIMV N/A
- AMRN N/A
- EPS Growth
- ZIMV N/A
- AMRN N/A
- EPS
- ZIMV N/A
- AMRN N/A
- Revenue
- ZIMV $443,551,000.00
- AMRN $214,112,000.00
- Revenue This Year
- ZIMV $1.96
- AMRN N/A
- Revenue Next Year
- ZIMV $1.95
- AMRN N/A
- P/E Ratio
- ZIMV N/A
- AMRN N/A
- Revenue Growth
- ZIMV N/A
- AMRN N/A
- 52 Week Low
- ZIMV $8.15
- AMRN $7.08
- 52 Week High
- ZIMV $22.18
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- ZIMV 87.34
- AMRN 53.71
- Support Level
- ZIMV $8.36
- AMRN $15.11
- Resistance Level
- ZIMV $18.98
- AMRN $16.21
- Average True Range (ATR)
- ZIMV 0.34
- AMRN 0.61
- MACD
- ZIMV 1.10
- AMRN -0.31
- Stochastic Oscillator
- ZIMV 98.12
- AMRN 20.17
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.